Omnichannel scientific engagement and the use of archetypes ...

One of the greatest commodities in the healthcare industry is the provision of medically relevant information to enable critical decision-making that ultimately optimizes patient outcomes.

Phesi launches AI-driven trial accelerator, saving $7m per t...

Yesterday, global provider of patient-centric data analytics, Phesi launched its AI-driven Trial Accelerator Platform, an

Battling breast cancer with precision medicine

Key operational considerations to optimise decentralised cli...

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly

Commercialization of novel gene-editing technology in beta-t...

Gene therapies and research into them have grown immensely in recent years, offering more novel tools in regenerative medicine to fight disease, including rare diseases and genetic disorders.